Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization (CDMO), published its first annual sustainability report, consolidating the company's policies for an enhanced ESG management system and related plans. The report focuses on the company's commitment to taking part in social responsibility over the past decade and its future plans for the next ten years and beyond.
Over a year into the global pandemic, Samsung Biologics continues to leverage innovative virtual platform for remote audits and regulatory inspections prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Samsung Biologics (KRX: 207940.KS), the world s leading contract development and manufacturing organization, signed a strategic partnership.
Farmacéuticas de EEUU acuerdan producir más vacunas contra COVID-19 en Corea del Sur - Tucumán Noticias - Agencia de Noticias - Diario de Tucumán tucumanoticias.com.ar - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tucumanoticias.com.ar Daily Mail and Mail on Sunday newspapers.
Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Modernas COVID-19 Vaccine financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.